Advertisement
U.S. markets closed

Theravance Biopharma, Inc. (TBPH)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
8.97-0.04 (-0.44%)
At close: 04:00PM EDT
8.97 0.00 (0.00%)
After hours: 04:05PM EDT
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts3333
Avg. Estimate-0.25-0.22-0.64-0.32
Low Estimate-0.4-0.28-0.96-0.75
High Estimate-0.16-0.18-0.30.32
Year Ago EPS-0.35-0.28-1-0.64
Revenue EstimateCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts3333
Avg. Estimate14.92M15.89M74.33M86.37M
Low Estimate14M15M63.89M76.95M
High Estimate15.75M17.18M87.5M96.55M
Year Ago Sales13.84M13.75M57.42M74.33M
Sales Growth (year/est)7.80%15.60%29.40%16.20%
Earnings History3/30/20236/29/20239/29/202312/30/2023
EPS Est.-0.26-0.21-0.21-0.15
EPS Actual-0.35-0.28-0.17-0.17
Difference-0.09-0.070.04-0.02
Surprise %-34.60%-33.30%19.00%-13.30%
EPS TrendCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Current Estimate-0.25-0.22-0.64-0.32
7 Days Ago-0.25-0.22-0.64-0.32
30 Days Ago-0.25-0.23-0.61-0.2
60 Days Ago-0.25-0.23-0.61-0.2
90 Days Ago-0.25-0.23-0.61-0.2
EPS RevisionsCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days1121
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesTBPHIndustrySector(s)S&P 500
Current Qtr.28.60%N/AN/AN/A
Next Qtr.21.40%N/AN/AN/A
Current Year36.00%N/AN/AN/A
Next Year50.00%N/AN/AN/A
Next 5 Years (per annum)54.10%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A